These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 32366560)
1. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma. Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560 [TBL] [Abstract][Full Text] [Related]
2. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203 [TBL] [Abstract][Full Text] [Related]
4. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma. Yin J; Hou P; Wu Z; Wang T; Nie Y Tumour Biol; 2015 Jun; 36(6):4501-7. PubMed ID: 25618599 [TBL] [Abstract][Full Text] [Related]
5. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Chen L; Chu F; Cao Y; Shao J; Wang F Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466 [TBL] [Abstract][Full Text] [Related]
6. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940 [TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma. Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713 [TBL] [Abstract][Full Text] [Related]
8. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival. Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448 [TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356 [TBL] [Abstract][Full Text] [Related]
10. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma. Wang F; Ying H; He B; Pan Y; Sun H; Wang S Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720 [TBL] [Abstract][Full Text] [Related]
11. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L; Xu Q; Xie H; Gu G; Jiang J Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116 [TBL] [Abstract][Full Text] [Related]
12. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
13. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
14. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
15. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation. Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346 [TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value. Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293 [TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of tumor-educated platelet microRNAs in patients with hepatocellular carcinoma. Zhu B; Gu S; Wu X; He W; Zhou H Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34806748 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]